Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Scherrer

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
The Journal of Antimicrobial Chemotherapy|January 22, 2017
Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patientsC Sekaggya-Wiltshire, A von Braun, A U Scherrer, et al.
AIDS (London, England)|July 19, 2014
Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patientsKarin J Metzner, Alexandra U Scherrer, Viktor von Wyl, et al.
CMAJ Open|December 9, 2014
The effects of HIV-1 subtype and ethnicity on the rate of CD4 cell count decline in patients naive to antiretroviral therapy: a Canadian-European collaborative retrospective cohort studyMarina B Klein, Jim Young, David Dunn, et al.
Scientific Reports|June 15, 2016
Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in SwitzerlandMohaned Shilaih, Alex Marzel, Wan Lin Yang, et al.
BMC Infectious Diseases|April 14, 2012
Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infectionJörg Schüpbach, Leslie R Bisset, Martin D Gebhardt, et al.
Plos Neglected Tropical Diseases|June 19, 2015
Toward Measuring Schistosoma Response to Praziquantel Treatment with Appropriate Descriptors of Egg ExcretionPiero L Olliaro, Michel Vaillant, Aïssatou Diawara, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
First results of a national deployment of a fully automated central-line-associated bloodstream infection (CLABSI) surveillance system, Switzerland, 2022 to 2023Gaud Catho, Jason Toko, Loïc Fortchantre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 8, 2020
Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase InhibitorsElisabeth Deutschmann, Heiner C Bucher, Steffen Jaeckel, et al.
Molecular Biology and Evolution|October 14, 2017
Dissecting HIV Virulence: Heritability of Setpoint Viral Load, CD4+ T-Cell Decline, and Per-Parasite PathogenicityFrederic Bertels, Alex Marzel, Gabriel Leventhal, et al.
Open Forum Infectious Diseases|September 23, 2022
Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency VirusBernadette Jakeman, Alexandra U Scherrer, Katharine E A Darling, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
The Journal of Antimicrobial Chemotherapy|January 22, 2017
Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patientsC Sekaggya-Wiltshire, A von Braun, A U Scherrer, et al.
AIDS (London, England)|July 19, 2014
Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patientsKarin J Metzner, Alexandra U Scherrer, Viktor von Wyl, et al.
CMAJ Open|December 9, 2014
The effects of HIV-1 subtype and ethnicity on the rate of CD4 cell count decline in patients naive to antiretroviral therapy: a Canadian-European collaborative retrospective cohort studyMarina B Klein, Jim Young, David Dunn, et al.
Scientific Reports|June 15, 2016
Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in SwitzerlandMohaned Shilaih, Alex Marzel, Wan Lin Yang, et al.
BMC Infectious Diseases|April 14, 2012
Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infectionJörg Schüpbach, Leslie R Bisset, Martin D Gebhardt, et al.
Plos Neglected Tropical Diseases|June 19, 2015
Toward Measuring Schistosoma Response to Praziquantel Treatment with Appropriate Descriptors of Egg ExcretionPiero L Olliaro, Michel Vaillant, Aïssatou Diawara, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
First results of a national deployment of a fully automated central-line-associated bloodstream infection (CLABSI) surveillance system, Switzerland, 2022 to 2023Gaud Catho, Jason Toko, Loïc Fortchantre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 8, 2020
Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase InhibitorsElisabeth Deutschmann, Heiner C Bucher, Steffen Jaeckel, et al.
Molecular Biology and Evolution|October 14, 2017
Dissecting HIV Virulence: Heritability of Setpoint Viral Load, CD4+ T-Cell Decline, and Per-Parasite PathogenicityFrederic Bertels, Alex Marzel, Gabriel Leventhal, et al.
Open Forum Infectious Diseases|September 23, 2022
Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency VirusBernadette Jakeman, Alexandra U Scherrer, Katharine E A Darling, et al.
Pageof 14